HHS Extends Partnership with Regeneron to Develop Life-Saving Monoclonal Antibodies Contracts + Grants September 8, 2023 …
CSL Seqirus Awarded Contract for Influenza A(H5N8) Candidate Vaccine Medical Countermeasures August 28, 2023 …
Allucent Awarded BARDA Contract to Accelerate Next-Generation COVID-19 Booster Vaccines Medical Countermeasures August 28, 2023 …
Project NextGen: HHS Awards $1.4B for COVID Countermeasure Development Contracts + Grants August 22, 2023 …
BARDA-Supported Anthrax Vaccine Now Approved, Enables Faster Onset to Protection Industry News August 7, 2023 …
U.S. Invests in mAb Treatment for Ebola with New Award to Emergent BioSolutions Industry News July 31, 2023 …
After Missing the Mark in COVID Trial, Revive Therapeutics Pursues Bucillamine as CBRN Medical Countermeasure Industry News July 28, 2023 …
Smallpox Countermeasures: U.S. Awards $138M to Siga Technologies for TPOXX Industry News July 27, 2023 …
Sabin Vaccine Institute to Advance Ebola Sudan and Marburg Vaccines with New BARDA Funding Industry News January 12, 2023 …
Protection from Biothreats: DOD to Modernize Medical Countermeasures Development CBRNE January 10, 2023 …
Texas Biomed at Forefront of Sudan ebolavirus Vaccine Development Medical Countermeasures December 27, 2022 …
BugSeq Awarded BARDA DRIVe Funding to Develop Next-Gen Diagnostics for Any Respiratory RNA Virus Health Security May 3, 2022 …
Rapid COVID-19 PCR Test Developed at Northwestern Receives FDA Emergency Use Authorization Biodetection March 19, 2022 …
Medical Countermeasures Surge Capacity Act of 2022 Introduced in Senate Policy + Initiatives February 7, 2022 …
US Government Invests in At-Home Single Swab Combined Flu, COVID Test Biodetection February 3, 2022 …
